Published on 19 Jul 2024 on Benzinga · via Yahoo Finance
Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
On Sunday, Longeveron Inc (NASDAQ:LGVN) presented Phase 2a clinical trial data and biomarker results at the Alzheimer’s Association International Conference (AAIC).
The Phase 2a CLEAR MIND trial evaluated 48 patients (36 were treated with Lomecel-B, and 12 received placebo).